Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says.Watch here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHarvey Nash Group Regulatory News (HVN)

  • There is currently no data for HVN

Director/PDMR Shareholding

29 Oct 2018 07:00

RNS Number : 3880F
Harvey Nash Group PLC
29 October 2018
 

29 October 2018

 

Director/PDMR Shareholding

Harvey Nash Group Plc

("the Company")

Notification of Transaction by Directors

In accordance with DTR 3.1 and Article 19 of The Market Abuse Regulation, the Company was advised on 26 October 2018 that Albert Ellis, Simon Wassall and Mark Garratt had acquired ordinary shares in London on 26 October 2018 at a price of £0.05 per ordinary share as a result of the exercise of options granted under the Company's Performance Share Plan which became exercisable as a result of the offer by The Power of Talent Ltd being declared wholly unconditional on 26 October 2018:

Director

Number of shares purchased

Price per share

Resulting holding

Albert Ellis

1,385,499

£0.05

2,267,084*

Simon Wassall

930,215

£0.05

1,259,331

Mark Garratt

381,229

£0.05

416,787

*Includes 658,923 ordinary shares held by family members.

The notification below provides further detail.

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them. 

1

Details of the person discharging managerial responsibility

a)

Name

Albert Ellis

2

Reason for the notification

a)

Position/status

Chief Executive

 

b)

Initial notification/amendment

Initial notification

 

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Full name of the entity

Harvey Nash Group plc

b)

Legal Entity Identifier Code

2138004ULQUX3DQSCV07

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Ordinary shares of £0.05 each

ISIN: GB0006573546

c)

Nature of the transaction

Acquisition through Company Performance Share Plan.

e)

Price(s) and Volume(s)

Exercise:

Price(s) per share

Volume(s)

Aggregate Price

£0.05

1,385,499

£69,274.95

 

 

 

g)

Date of transaction

26 October 2018

h)

Place of transaction

London Stock Exchange XLON

 

1

Details of the person discharging managerial responsibility

a)

Name

Simon Wassall

2

Reason for the notification

a)

Position/status

European Managing Director

 

b)

Initial notification/amendment

Initial notification

 

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Full name of the entity

Harvey Nash Group plc

b)

Legal Entity Identifier Code

2138004ULQUX3DQSCV07

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Ordinary shares of £0.05 each

ISIN: GB0006573546

c)

Nature of the transaction

Acquisition through Company Performance Share Plan.

e)

Price(s) and Volume(s)

Exercise:

Price(s) per share

Volume(s)

Aggregate Price

£0.05

930,215

£46,510.75

 

 

 

g)

Date of transaction

26 October 2018

h)

Place of transaction

London Stock Exchange XLON

 

1

Details of the person discharging managerial responsibility

a)

Name

Mark Garratt

2

Reason for the notification

a)

Position/status

Group Finance Director

 

b)

Initial notification/amendment

Initial notification

 

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Full name of the entity

Harvey Nash Group plc

b)

Legal Entity Identifier Code

2138004ULQUX3DQSCV07

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Ordinary shares of £0.05 each

ISIN: GB0006573546

c)

Nature of the transaction

Acquisition through Company Performance Share Plan.

e)

Price(s) and Volume(s)

Exercise:

Price(s) per share

Volume(s)

Aggregate Price

£0.05

381,229

£19,061.45

 

 

 

g)

Date of transaction

26 October 2018

h)

Place of transaction

London Stock Exchange XLON

 

Contact:

Mark Garratt, Group Finance Director - 020 7333 0033

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DSHFEUFMMFASEES
Date   Source Headline
28th Nov 20089:29 amRNSTransfer of Shares
28th Nov 20087:00 amRNSInterim Management Statement
24th Nov 200810:01 amRNSAdditional Listing
12th Nov 200811:15 amRNSAdditional Listing
11th Nov 20087:00 amRNSPartnership Update
31st Oct 20087:00 amRNSTotal Voting Rights
17th Oct 200811:09 amRNSInterim Report 2008
1st Oct 20087:46 amRNSTotal Voting Rights
30th Sep 20087:00 amRNSInterim Results
18th Sep 200810:18 amRNSTransfer of Shares
5th Sep 20085:49 pmRNSHolding(s) in Company
1st Sep 20088:57 amRNSTotal Voting Rights
12th Aug 200811:29 amRNSHolding(s) in Company
4th Aug 20087:00 amRNSNotice of Results
1st Aug 20087:11 amRNSTotal Voting Rights
31st Jul 200811:25 amRNSHolding(s) in Company
24th Jul 20087:32 amRNSHolding(s) in Company
11th Jul 20081:10 pmRNSHolding(s) in Company
9th Jul 20083:29 pmRNSHolding(s) in Company
8th Jul 20087:00 amRNSDirector/PDMR Shareholding
3rd Jul 20084:56 pmRNSResult of AGM
1st Jul 20088:33 amRNSTotal Voting Rights
19th Jun 20087:00 amRNSInterim Management Statement
13th Jun 20087:22 amRNSBlocklisting Interim Review
5th Jun 200810:35 amRNSAnnual Report and Accounts
4th Jun 20087:00 amRNSDirector/PDMR Shareholding
4th Jun 20087:00 amRNSDirector/PDMR Shareholding
4th Jun 20087:00 amRNSDirector/PDMR Shareholding
2nd Jun 20089:08 amRNSTotal Voting Rights
28th May 20082:23 pmRNSHolding(s) in Company
28th May 200810:25 amRNSTransfer of Shares
23rd May 20087:00 amRNSAnnual Information Update
19th May 20081:18 pmRNSHolding(s) in Company
1st May 20089:12 amRNSTotal Voting Rights
22nd Apr 20087:00 amRNSDirector/PDMR Shareholding
21st Apr 200811:18 amRNSHolding(s) in Company
17th Apr 200811:46 amRNSRe Dividend
17th Apr 20087:01 amRNSFinal Results
1st Apr 20088:58 amRNSTotal Voting Rights
26th Mar 200811:33 amRNSTransfer of Shares
29th Feb 20087:00 amRNSTotal Voting Rights
1st Feb 20089:28 amRNSTotal Voting Rights
7th Jan 200810:11 amRNSHolding(s) in Company
7th Jan 200810:05 amRNSHolding(s) in Company
2nd Jan 200810:04 amRNSTotal Voting Rights
20th Dec 20077:01 amRNSInterim Management Statement
13th Dec 20079:41 amRNSBlocklisting Interim Review
30th Nov 20077:00 amRNSTotal Voting Rights
8th Nov 200710:11 amRNSTransfer of Shares
5th Nov 20077:01 amRNSStrategic Alliance

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.